Kiwi skin cancer experts are supporting a smartphone app that claims to monitor and detect melanoma risk, but are warning against relying on it completely.
SkinVision is described in the App Store as a "skin monitor" for melanoma, skin cancer and risky moles, and markets itself as a "melanoma detection app".
Dr Amanda Oakley, an associate professor at the University of Auckland's Waikato Clinical Campus, said the app-makers approached New Zealand.
"I'm absolutely delighted to support any venture we can to get people to go to their doctors if they have lesions of concern," she said.
Oakley is assessing it and others on the market as part of a study into the value and safety of consumer skin cancer monitoring devices compared to professional devices.